Robert Andrade - 18 Feb 2026 Form 4 Insider Report for FENNEC PHARMACEUTICALS INC. (FENC)

Role
CHIEF FINANCIAL OFFICER
Signature
/s/ Robert Andrade
Issuer symbol
FENC
Transactions as of
18 Feb 2026
Net transactions value
$0
Form type
4
Filing time
19 Feb 2026, 18:43:44 UTC
Previous filing
02 Feb 2026
Next filing
03 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Andrade Robert CHIEF FINANCIAL OFFICER C/O FENNEC PHARMACEUTICALS, INC., PO BOX 13628, 68 TW ALEXANDER DRIVE, RESEARCH TRIANGLE PARK /s/ Robert Andrade 19 Feb 2026 0001468308

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FENC Common shares Options Exercise $9,996 +2,450 +1.2% $4.08 215,108 18 Feb 2026 Direct F1
transaction FENC Common shares Options Exercise $0 +27,285 +13% $0.000000 242,393 18 Feb 2026 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FENC Stock Options Options Exercise $9,996 -2,450 -0.3% $4.08 814,117 18 Feb 2026 Options 2,450 $4.08 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares acquired through the exercise of an option contract with strike price of $4.08 and an expiration date of December 20, 2031.
F2 Represents settlement of PSUs that vested on February 18, 2026.